Spending on cancer drugs in the United States has now exceeded $56 billion and the median annual cost of a new cancer...
While the practice of healthcare continues to make advances in patient care with new research, procedures, and drug therapies, the...
Learn how payers can curb out-of-control cancer costs and address the inevitable swing to consumer-driven approaches to care. This webcast...
Innovative new treatments and advanced therapies have provided a fundamental shift in oncology care. This evolution has transformed outcomes for...
Biosimilars are becoming quite the buzzword in cancer treatment, but cost, regulation, safety and efficacy are driving questions amongst payers...
Webcast Presentation Wednesday, June 6, 2018 4:00 p.m. ET NantHealth Webcast 4:00 p.m. ET Click here for webcast NantHealth &...